3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
72
Precursor Cell Lymphoblastic Leukemia-Lymphoma
66
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Non-Hodgkin
33
Leukemia
33
Burkitt Lymphoma
33
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
19
Recurrence
13
Lymphoma, B-Cell
13
Hodgkin Disease
13
Neoplasms
11
Lymphoma, Large-Cell, Anaplastic
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Sarcoma
9
Neuroblastoma
8
Multiple Myeloma
8
Medulloblastoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
7
Central Nervous System Neoplasms
7
Rhabdomyosarcoma
6
Leukemia, Biphenotypic, Acute
6
Lymphoma, B-Cell, Marginal Zone
5
Wilms Tumor
4
Waldenstrom Macroglobulinemia
4
Sarcoma, Ewing
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Lymphoma, Large-Cell, Immunoblastic
4
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Vincristine
×
Clear all
No trials found.